Verbatim response from ChatGPT
Short answer
- “Bioidentical” refers to hormones that have the same molecular structure as the hormones made by the human body (for example, estradiol and micronized progesterone).
- “Standard” HRT (hormone replacement therapy) usually means FDA‑approved hormone drugs and combinations—these include both hormones that are identical to human hormones and synthetic progestins that are not identical. The big differences are regulatory oversight, consistency, evidence about safety and effectiveness, and how the products are made/delivered.
Details you should know
- What “bioidentical” means: bioidentical hormones are chemically identical to natural human hormones (examples: 17β‑estradiol and micronized progesterone). They can be produced by pharmaceutical manufacturers (FDA‑approved products) or made by compounding pharmacies (custom formulations).
- Two categories often get compared:
- FDA‑approved bioidentical products: manufactured under strict standards, consistent dosing and purity, and supported by clinical trials and product labeling. Examples: Estrace (oral estradiol), Vivelle‑DOT/Climara/Alora (estradiol patches), Vagifem or Estring (local vaginal estradiol), Prometrium (micronized progesterone). Bijuva is an FDA‑approved combination of estradiol + micronized progesterone for menopause symptoms.
- Compounded “bioidentical” hormones: custom mixtures made by compounding pharmacies (often advertised as “natural,” tailored doses, saliva testing used to pick doses). These are not FDA‑approved as finished products, so they lack the same premarket testing for safety, potency and consistency.
- Standard HRT sometimes uses synthetic progestins (not bioidentical), for example medroxyprogesterone acetate (Provera) or norethindrone. Those have different effects and risk profiles than micronized progesterone.
Safety and evidence
- FDA‑approved options: dosing, purity and side effects are well studied. Because they’re regulated, you get predictable potency, and clinical trial data inform risks and benefits.
- Compounded BHRT: may vary in strength and purity between batches; fewer large controlled trials proving safety or effectiveness; not usually covered by insurance.
- Some differences in risks by type and route:
- Transdermal estradiol (patches/gels) may have lower risk of blood clots than oral estrogen.
- Micronized progesterone may have a different breast‑cancer and cardiovascular risk profile than some synthetic progestins in observational studies, but data aren’t definitive.
- Beware marketing claims that bioidentical = completely safe or “natural” = safer. Safety depends on dose, route, which hormone, individual risk factors (age, time since menopause, smoking, personal/family history).
Practical recommendations
- If you want bioidentical hormones, ask first about FDA‑approved bioidentical options (estradiol products, Prometrium, Bijuva). These give laboratory‑grade consistency and have clinical data.
- If considering compounded BHRT, use a reputable, accredited compounding pharmacy (look for PCAB accreditation), ask for lot testing/certificate of analysis, and understand it may not be covered by insurance.
- Don’t rely on saliva tests to dose hormones—these are generally not validated for menopause management. Serum hormone testing and clinical symptom assessment are more useful in most cases.
- If you have a uterus, you generally need a progestogen (to protect the endometrium from estrogen-driven hyperplasia); discuss progesterone vs synthetic progestin with your clinician.
- Discuss individualized risks (heart disease, stroke, blood clots, breast cancer, VTE) with your provider and get regular follow‑up after starting therapy.
If you want, I can
- Compare specific products (patch vs pill vs vaginal) for your symptoms and risk profile,
- Find local PCAB‑accredited compounding pharmacies,
- Summarize the main studies on micronized progesterone vs synthetic progestins.
Which would you like to do next?